domingo, 16 de febrero de 2025

Sotagliflozin could be used to reduce the risk of deadly cardiovascular events, trial shows

https://www.news-medical.net/news/20250214/Sotagliflozin-could-be-used-to-reduce-the-risk-of-deadly-cardiovascular-events-trial-shows.aspx

No hay comentarios:

Publicar un comentario